![]() |
市場調查報告書
商品編碼
2035269
實驗室培育咖啡市場預測至2034年-按產品類型、生產技術、應用、通路、最終用戶和地區分類的全球分析Lab-Grown Coffee Market Forecasts to 2034 - Global Analysis By Product Type, Production Technology, Application, Distribution Channel, End User and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球實驗室培育咖啡市場規模將達到 12 億美元,並在預測期內以 14.7% 的複合年成長率成長,到 2034 年將達到 36 億美元。
實驗室培育咖啡是指利用細胞農業技術、發酵生物合成、生物反應器培養和合成生物學製程所生產的咖啡飲料、萃取物和功能性混合咖啡。這些工藝包括培養咖啡植物細胞、複製咖啡化合物的生物合成途徑,或精確發酵風味前體化合物,從而在不採用傳統咖啡豆種植方式的情況下,生產出具有與正宗咖啡相似的香氣、咖啡因含量和風味特徵的產品。這解決了與傳統咖啡生產相關的供應鏈永續性、森林砍伐、氣候變遷脆弱性和公平貿易問題。
咖啡供應鏈的永續性危機
除了氣候變遷導致巴西和衣索比亞等主要阿拉比卡咖啡產區產量下降外,咖啡種植面積擴張引發的森林砍伐問題也加劇了供應鏈永續性的迫切性。這促使食品科技公司投資研發「實驗室培育咖啡」替代品,這類產品不僅能提供與傳統咖啡相似的風味,還能大幅減少土地、水資源和碳排放。大型咖啡公司在永續性的努力也提高了人們對實驗室培育咖啡替代品商業性試驗計畫的興趣。
生產規模上的經濟差距
利用生物反應器培養和細胞農業技術生產實驗室咖啡的成本仍然遠高於購買生咖啡豆的成本,這是其商業性化應用的主要障礙。要實現與傳統咖啡產品相當的消費者價格,需要大量的技術投資和生產規模的擴大,因此短期內其商業化僅限於高階小眾市場和注重永續發展的細分市場,尚未達到足以取代整體咖啡消費的規模。
透過增強功能性咖啡優質化
實驗室培育咖啡生產技術能夠在細胞生物合成過程中精準地添加促智化合物、適應原植物成分和特定抗氧化劑等功能性成分,這為功能性咖啡配方帶來了高階市場機遇,使其能夠實現傳統烘焙方法無法實現的成分組合。這使得實驗室培育咖啡品牌能夠將自身定位為一種新型的健康功能性高階咖啡體驗,並獲得與其傳統產品相區別的溢價。
消費者對真實性和懷疑精神的偏好
與那些講述風土故事的農場種植的專門食品咖啡相比,消費者對實驗室生產的咖啡飲品的懷疑態度,對消費者接受度構成了根本性的挑戰。優質咖啡文化和專門食品咖啡市場的美學理念強調真實的農業產地、手工加工和地理風土,而這些從根本上來說是實驗室生產的技術效率無法複製的,無論其在香氣和風味特徵的準確性方面多麼成功。
新冠疫情造成的供應鏈中斷暴露了咖啡市場的脆弱性,並提高了消費者對食品系統韌性不足的認知。這促使投資者和企業將目光轉向替代食品生產技術,包括實驗室培育咖啡,將其視為供應鏈自給自足的策略。疫情後永續發展投資的動能以及人們對氣候變遷帶來的農業風險認知的提高,持續推動著食品科技企業的資金籌措,尤其是在實驗室培育咖啡新創企業的發展方面,一些商業試驗計畫正朝著有限市場化邁進。
在預測期內,咖啡濃縮液細分市場預計將佔據最大的市場佔有率。
在預測期內,咖啡濃縮液液預計將佔據最大的市場佔有率。這是因為濃縮液體咖啡萃取物的應用能夠將實驗室培養的咖啡成分有效地整合到即飲咖啡飲料、餐飲服務業和家庭烹飪系統中,這些領域需要的是標準化、濃縮的風味,而非從傳統研磨咖啡豆中提取。這為將實驗室培養的咖啡成分初步引入現有咖啡產品供應鏈提供了最具商業性可行性的形式。
預計在預測期內,細胞農業領域將呈現最高的複合年成長率。
在預測期內,細胞農業領域預計將呈現最高的成長率。這主要得益於大量創業投資和企業對咖啡細胞培養技術公司(例如Atomo Coffee和Compound Foods)的投資,這些公司已取得關鍵性進展,例如建立了關鍵的風味特徵並降低了成本。此外,食品技術投資者對細胞農業商業性可行性的信心日益增強,從而為旨在早期、小規模地在注重永續性的高階市場推出商業產品的生產項目提供了資金籌措。
在預測期內,北美預計將佔據最大的市場佔有率。這是因為美國擁有最活躍的實驗室培育咖啡新創企業生態系統,例如總部位於西雅圖的Atomo Coffee和總部位於矽谷的Compound Foods等先鋒企業,以及豐富的食品科技行業創業投資投資資源,再加上主要大都會圈擁有大量具有永續發展意識的高階咖啡消費者,這些因素共同為新型咖啡技術產品的早期商業化部署創造了最有利的環境。
在預測期內,亞太地區預計將呈現最高的複合年成長率。這主要是因為新加坡和日本擁有充滿活力的食品科技監管沙盒環境,能夠促進實驗室培育食品和飲料產品的商業化;中國、韓國和澳洲快速發展的專門食品咖啡文化正在打造一個高階消費群體,他們對創新咖啡技術持開放態度;此外,新加坡和韓國政府對食品科技領域的大量投資也為替代蛋白和食品生產初創企業的生態系統提供了支持。
According to Stratistics MRC, the Global Lab-Grown Coffee Market is accounted for $1.2 billion in 2026 and is expected to reach $3.6 billion by 2034 growing at a CAGR of 14.7% during the forecast period. Lab-grown coffee refers to coffee beverages, extracts, and functional blends produced through cellular agriculture techniques, fermentation-based biosynthesis, bioreactor cultivation, and synthetic biology processes that cultivate coffee plant cells, reproduce coffee compound biosynthetic pathways, or precisely ferment flavor precursor compounds to generate authentic coffee aroma, caffeine content, and taste profiles without conventional coffee bean agricultural cultivation, addressing supply chain sustainability, deforestation, climate vulnerability, and fair trade concerns associated with traditional coffee production.
Coffee Supply Chain Sustainability Crisis
Climate change-driven coffee crop yield reduction across major Arabica growing regions in Brazil and Ethiopia combined with deforestation concerns from expanding coffee cultivation area is creating supply chain sustainability urgency that is driving food technology investment in lab-grown coffee alternatives capable of delivering authentic flavor profiles with a fraction of the land, water, and carbon footprint of conventional coffee cultivation. Major coffee company sustainability commitments are generating commercial pilot program interest in lab-grown alternatives.
Production Scale Economics Gap
Bioreactor cultivation and cellular agriculture production cost economics for lab-grown coffee remaining substantially higher than commodity green coffee procurement costs create significant commercial viability barriers that require substantial technology investment and production scale-up milestones to achieve consumer price parity with conventional coffee products, limiting near-term commercialization to niche premium sustainability-positioned market segments unable to represent meaningful total coffee consumption volume replacement.
Functional Coffee Fortification Premium
Lab-grown coffee production technology enabling precise incorporation of functional ingredients including nootropic compounds, adaptogenic botanicals, and specific antioxidant profiles during cellular biosynthesis processes represents a premium market opportunity for functional coffee formulations with ingredient combinations impossible in conventional roasted bean processing, enabling lab-grown coffee brands to position novel health-functional premium coffee experiences commanding pricing premiums over commodity alternatives.
Consumer Authenticity Skepticism
Consumer authenticity skepticism toward laboratory-produced coffee beverages compared to farm-origin specialty coffee with terroir provenance storytelling creates a fundamental consumer acceptance challenge as premium coffee culture values and specialty coffee market aesthetics emphasize authentic agricultural origin, artisan processing, and geographic terroir that lab-grown production fundamentally cannot replicate through technological efficiency regardless of aroma and flavor profile accuracy achievements.
COVID-19 supply chain disruptions exposing coffee market fragility and consumer awareness of food system resilience vulnerabilities generated investor and corporate attention toward alternative food production technologies including lab-grown coffee as supply chain independence strategies. Post-pandemic sustainability investment momentum and climate change agricultural risk awareness continue driving food technology venture funding toward lab-grown coffee startup development, with several commercial pilot programs progressing toward limited market launches.
The coffee concentrates segment is expected to be the largest during the forecast period
The coffee concentrates segment is expected to account for the largest market share during the forecast period, due to concentrated liquid coffee extract applications enabling efficient lab-grown coffee ingredient incorporation across ready-to-drink coffee beverage manufacturing, foodservice operations, and home preparation systems that require standardized concentrated flavor delivery rather than conventional ground bean brewing, providing the most commercially accessible format for initial lab-grown coffee ingredient deployment in established coffee product supply chains.
The cellular agriculture segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the cellular agriculture segment is predicted to witness the highest growth rate, driven by substantial venture capital and corporate investment in coffee cell culture technology companies including Atomo Coffee and Compound Foods that are achieving key flavor profile and cost reduction milestones, combined with growing food technology investor confidence in cellular agriculture commercial viability generating funding for production scale-up programs targeting initial limited commercial product launches in premium sustainability-focused markets.
During the forecast period, the North America region is expected to hold the largest market share, due to the United States hosting the most active lab-grown coffee startup ecosystem with pioneering companies including Atomo Coffee and Compound Foods headquartered in Seattle and Silicon Valley respectively, strong food technology venture capital availability, and premium sustainability-motivated coffee consumer demographics in major metropolitan markets providing the most receptive initial commercial launch environment for novel coffee technology products.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to Singapore and Japan hosting active food technology regulatory sandbox environments enabling lab-grown food and beverage product commercialization, rapidly growing specialty coffee culture in China, South Korea, and Australia creating premium consumer segments receptive to novel coffee innovation, and substantial government food technology investment in Singapore and South Korea supporting alternative protein and food production startup ecosystems.
Key players in the market
Some of the key players in Lab-Grown Coffee Market include Nestle S.A., Starbucks Corporation, JDE Peet's N.V., Lavazza Group, Tata Consumer Products Ltd., Atomo Coffee Inc., Compound Foods Inc., Fooditive B.V., Califia Farms LLC, Oatly Group AB, Perfect Day Inc., Ginkgo Bioworks, Impossible Foods Inc., Beyond Meat Inc., Kerry Group plc, Symrise AG, and International Flavors & Fragrances Inc..
In March 2026, Atomo Coffee Inc. announced its first limited commercial launch of molecular lab-grown cold brew coffee through select Seattle-area specialty retailers, marking the first consumer-available cellular agriculture coffee product at commercial scale.
In February 2026, Compound Foods Inc. secured Series B funding to accelerate bioreactor-based coffee compound fermentation production scale-up targeting ingredient supply partnerships with major ready-to-drink coffee manufacturers for sustainable sourcing programs.
In December 2025, Ginkgo Bioworks launched a food ingredient development partnership program with specialty coffee brands enabling customized lab-grown coffee flavor compound biosynthesis for unique flavor profiles differentiated from commodity coffee alternatives.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.